Results and learnings ... ‘managed entry scheme’ illustrate that early access with the promise of future evidence to confirm a medicine’s cost-effectiveness can work, but needs to be carefully considered, constructed and managed. #HQ_RWE_Works https://t.co
A real world example of coverage with evidence development in Australia - ipilimumab for the treatment of metastatic melanoma. https://t.co/QOV51DArif
#JPharmPolicyPract A real world example of coverage with evidence development in Australia - ipilimumab for the treatment of metastatic melanoma. https://t.co/CzUKrFfELv
A real world example of coverage with evidence development in Australia - ipilimumab for the treatment of metastatic melanoma https://t.co/3O8HG6nkBT